371 related articles for article (PubMed ID: 29926732)
1. Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.
Macedo AB; Resop RS; Martins LJ; Szaniawski MA; Sorensen ES; Spivak AM; Nixon DF; Jones RB; Planelles V; Bosque A
AIDS Res Hum Retroviruses; 2018 Sep; 34(9):769-777. PubMed ID: 29926732
[TBL] [Abstract][Full Text] [Related]
2. Modeling HIV-1 Latency Using Primary CD4
Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
Banga R; Procopio FA; Cavassini M; Perreau M
J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.
Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N
J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901
[TBL] [Abstract][Full Text] [Related]
5. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
6. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.
White CH; Moesker B; Beliakova-Bethell N; Martins LJ; Spina CA; Margolis DM; Richman DD; Planelles V; Bosque A; Woelk CH
PLoS Pathog; 2016 Nov; 12(11):e1006026. PubMed ID: 27898737
[TBL] [Abstract][Full Text] [Related]
8. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
9. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
Front Immunol; 2021; 12():720697. PubMed ID: 34531866
[TBL] [Abstract][Full Text] [Related]
10. Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.
Anderson JL; Mota TM; Evans VA; Kumar N; Rezaei SD; Cheong K; Solomon A; Wightman F; Cameron PU; Lewin SR
PLoS One; 2016; 11(7):e0158778. PubMed ID: 27383184
[TBL] [Abstract][Full Text] [Related]
11. Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.
Martins LJ; Bonczkowski P; Spivak AM; De Spiegelaere W; Novis CL; DePaula-Silva AB; Malatinkova E; Trypsteen W; Bosque A; Vanderkerckhove L; Planelles V
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):187-93. PubMed ID: 26171776
[TBL] [Abstract][Full Text] [Related]
12. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
Lassen KG; Hebbeler AM; Bhattacharyya D; Lobritz MA; Greene WC
PLoS One; 2012; 7(1):e30176. PubMed ID: 22291913
[TBL] [Abstract][Full Text] [Related]
13. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.
Jung U; Takahashi M; Rossi JJ; Burnett JC
Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717
[TBL] [Abstract][Full Text] [Related]
14. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.
Macedo AB; Novis CL; De Assis CM; Sorensen ES; Moszczynski P; Huang SH; Ren Y; Spivak AM; Jones RB; Planelles V; Bosque A
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282829
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells.
Couturier J; Orozco AF; Liu H; Budhiraja S; Siwak EB; Nehete PN; Sastry KJ; Rice AP; Lewis DE
Virol J; 2019 Feb; 16(1):22. PubMed ID: 30786885
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4
Yim LY; Lam KS; Luk TY; Mo Y; Lu X; Wang J; Cheung KW; Lui GCY; Chan DPC; Wong BCK; Lau TT; Ngan CB; Zhou D; Wong YC; Tan Z; Liu L; Wu H; Zhang T; Lee SS; Chen Z
J Virol; 2023 May; 97(5):e0027023. PubMed ID: 37042759
[TBL] [Abstract][Full Text] [Related]
17. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
Rochat MA; Schlaepfer E; Speck RF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
[TBL] [Abstract][Full Text] [Related]
18. HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.
Chavez L; Calvanese V; Verdin E
PLoS Pathog; 2015 Jun; 11(6):e1004955. PubMed ID: 26067822
[TBL] [Abstract][Full Text] [Related]
19. Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4
Kulpa DA; Talla A; Brehm JH; Ribeiro SP; Yuan S; Bebin-Blackwell AG; Miller M; Barnard R; Deeks SG; Hazuda D; Chomont N; Sékaly RP
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578289
[TBL] [Abstract][Full Text] [Related]
20. A CCR5
Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
